Is Onco-Innovations Ltd halal to invest in?

According to Musaffa's Shariah screening methodology, Onco-Innovations Ltd (ONCO.NE) is currently classified as NOT HALAL as of April 2026. The classification is based on an evaluation of the company's business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Is Onco-Innovations Ltd a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Onco-Innovations Ltd using these criteria to determine its compliance status.

Can Muslims buy shares of Onco-Innovations Ltd?

Muslim investors may consider investing in Onco-Innovations Ltd if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is Onco-Innovations Ltd classified as NOT HALAL?

Musaffa determines the Shariah status of Onco-Innovations Ltd by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for Onco-Innovations Ltd updated?

The Shariah compliance status of Onco-Innovations Ltd may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like Onco-Innovations Ltd become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of Onco-Innovations Ltd?

You can check the latest Shariah compliance status of Onco-Innovations Ltd on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

ONCO.NE Shariah Compliance

Screening Methodology: AAOIFI

NOT HALAL

Last Updated: April 10, 2026

Report Source: 2026 3rd Quarter Report

Onco-Innovations Ltd. Stock Analysis ONCO.NE

Canada Health Care Micro Cap Report: Q3, 2026

Onco-Innovations Ltd. is a Canadian biotech company, which engages in cancer research and treatment, specializing in oncology. The company is headquartered in Calgary, Alberta. The company went IPO on 2024-11-27. Its product candidate is ONC010, which is an inhibitor of the deoxyribonucleic acid (DNA) repair enzyme Polynucleotide Kinase 3'-Phosphatase (PNKP) in a nanoparticle formulation based on drug delivery technology. ONC010 has undergone in-vitro and in-vivo testing in human cancer cells and mice, respectively, and has the ability to increase the effectiveness of cancer treatments, as well as induce synthetic lethality in phosphatase and tensin homologue (PTEN)-deficient cells. Its research and development roadmap covers manufacturing, discovery, pre-clinical testing, and clinical translation activities. The Clinical Translation program includes Phase I to Phase III clinical trials. Through its SynoGraph artificial intelligence platform, it enhances precision oncology by accelerating patient identification, optimizing treatment planning, and streamlining drug development across its pipeline.

Key Statistics of Onco-Innovations Ltd (ONCO.NE)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

CAD1.02CAD1.06

Today's Open

CAD1.02

Volume

19.22K

P/E Ratio (TTM)

52 Week Range

CAD0.50CAD2.38

Market Cap

84.60M

Avg. Volume

70.87K

Dividend Yield

Financial Metrics & Statements of Onco-Innovations Ltd (ONCO.NE)

FAQ's for Onco-Innovations Ltd (ONCO.NE)

According to Musaffa’s Shariah screening methodology, Onco-Innovations Ltd (ONCO.NE) is currently classified as NOT HALAL as of April 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.